BlackRock Health Sciences Trust
BME- Exchange
- NYSE
- SEC CIK
- 0001314966
No open-market purchases or sales by BlackRock Health Sciences Trust insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $111.9M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +2 vs. previous quarter
- 79
- 13F valueReported value at the end of Q2 2026
- $111.9M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding BME, Q2 2026
No superinvestor reported holding BME at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by BlackRock Health Sciences Trust insiders from Form 4, newest first.
No open-market purchases or sales by BlackRock Health Sciences Trust insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in BlackRock Health Sciences Trust at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 364,745 | $15.7M | 0.00% | +6,827+1.9% | Added |
| Bank of America Corp | 275,369 | $11.8M | 0.00% | +8,870+3.3% | Added |
| 1607 Capital Partners, LLC | 163,553 | $7.02M | 0.61% | −69,707−29.9% | Reduced |
| Wells Fargo & Company | 159,824 | $6.86M | 0.00% | +6,897+4.5% | Added |
| Royal Bank of Canada | 154,876 | $6.65M | 0.00% | −5,806−3.6% | Reduced |
| Nova R Wealth, Inc. | 140,936 | $6.05M | 1.77% | −13,681−8.8% | Reduced |
| Karpus Management, Inc. | 140,338 | $6.03M | 0.17% | −1,104−0.8% | Reduced |
| Invesco Ltd. | 130,083 | $5.59M | 0.00% | −4,569−3.4% | Reduced |
| LPL Financial LLC | 113,128 | $4.86M | 0.00% | +5,367+5.0% | Added |
| Raymond James Financial Inc | 109,811 | $4.72M | 0.00% | +2,375+2.2% | Added |